Kiyatec Announces executive changes

Kiyatec announced the appointment of Eric Perreault to the position of President and Tessa DesRochers as Vice President of Pre-Clinical Services.

Eric Perreault has been an integral part of the Kiyatec team and has played a crucial role in shaping the company’s strategic direction. With his 28 years of diagnostic commercial experience and leadership acumen, As President, Eric will spearhead the company’s efforts to achieve commercial success by driving innovation, forging strategic partnerships, and expanding market reach.

As Vice President of Pre-Clinical Services, Tessa DesRochers brings a wealth of expertise in cellular biology and translational medicine.

Kiyatec is a biotechnology company focused on advancing cancer research and drug development through innovative 3D cell culture technology.